201 related articles for article (PubMed ID: 15273128)
1. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Sader HS; Fedler KA; Rennie RP; Stevens S; Jones RN
Antimicrob Agents Chemother; 2004 Aug; 48(8):3112-8. PubMed ID: 15273128
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
Antimicrob Agents Chemother; 2008 Mar; 52(3):1187-9. PubMed ID: 18180345
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
11. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses.
Willcox MD; Hume EB; Aliwarga Y; Kumar N; Cole N
J Appl Microbiol; 2008 Dec; 105(6):1817-25. PubMed ID: 19016975
[TBL] [Abstract][Full Text] [Related]
12. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
13. Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties.
Pál T; Abraham B; Sonnevend A; Jumaa P; Conlon JM
Int J Antimicrob Agents; 2006 Jun; 27(6):525-9. PubMed ID: 16713189
[TBL] [Abstract][Full Text] [Related]
14. Sequence requirements and an optimization strategy for short antimicrobial peptides.
Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains.
Park Y; Park SC; Kim JY; Park JO; Seo CH; Nah JW; Hahm KS
Int J Antimicrob Agents; 2010 Feb; 35(2):208-9. PubMed ID: 20005677
[No Abstract] [Full Text] [Related]
16. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.
Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R
Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192
[TBL] [Abstract][Full Text] [Related]
17. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides.
Melo MN; Dugourd D; Castanho MA
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):201-7. PubMed ID: 18221145
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
[TBL] [Abstract][Full Text] [Related]
20. A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts.
Nuding S; Fellermann K; Wehkamp J; Mueller HA; Stange EF
J Microbiol Methods; 2006 May; 65(2):335-45. PubMed ID: 16182394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
